Prosztatarák: vizsgálatok itt: Kína
253 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
- Where
- Beijing, Changsha, Hangzhou
- Életkor
- 18 év to 75 év
- People
- 110
- Run by
- Hangzhou DAC Biotechnology Co., Ltd.
See details and how to joinNCT06926283 - 1. fázisTaking peopleA Study of DXC014 in Patients With Advanced Solid Tumors.
- Where
- Beijing, Changsha, Hangzhou, Nanchang, Qingdao
- Életkor
- 18 év and over
- People
- 150
- Run by
- Hangzhou DAC Biotechnology Co., Ltd.
See details and how to joinNCT07177937 - 2. fázisNot yet taking people in KínaDiagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study
- Where
- Wuhan
- Életkor
- 18 év to 90 év
- People
- 50
- Run by
- Yong He
See details and how to joinNCT07830212 - 2/3. fázisTaking peopleOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Where
- Beijing, Chengdu, Fuzhou, Guangzhou, Nanjing, Shanghai, Shenyang, Tianjin, Wuhan, Xian
- Életkor
- 18 év to 100 év
- People
- 443 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06780670 · EU 2024-512342-42-00 - 1/2. fázisTaking peopleA Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
- Where
- Harbin, Shanghai
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06568094 - 3. fázisTaking peopleThis Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.
- Where
- Nanjing, Wuxi
- Életkor
- 18 év and over
- People
- 232
- Run by
- Norroy Bioscience Co., LTD
See details and how to joinNCT07649122 - No phaseCsak meghívásosDevelopment and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT
- Where
- Beijing, Guangzhou, Jinan, Shanghai
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT07690306 - No phaseNot yet taking people in KínaSpatial Multi-Omics of Perineural Invasion Microenvironment and Prognosis in Prostate Cancer
- Where
- Hefei
- Életkor
- 18 év to 85 év
- People
- 120
- Run by
- Anhui Medical University
See details and how to joinNCT07818395 - No phaseNot yet taking people in KínaIntratumoral Microbiota and Immune Microenvironment in Prostate Cancer
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 100
- Run by
- Anhui Medical University
See details and how to joinNCT07818421 - 2. fázisNot yet taking people in KínaPSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
- Where
- Chengdu
- Életkor
- 18 év to 85 év
- People
- 254
- Run by
- West China Hospital
See details and how to joinNCT07649421 - Korai 1. fázisTaking peopleThe Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 10
- Run by
- FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07468708 - No phaseTaking peopleProstate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
- Where
- Hefei, Qingdao, Tianjin
- Életkor
- 18 év to 80 év
- People
- 500
- Run by
- Tianjin Medical University
See details and how to joinNCT06690970 - 1. fázisTaking peopleA Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 118
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07735377 - Korai 1. fázisTaking peopleThe Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
- Where
- Wuxi
- Életkor
- 18 év and over
- People
- 13
- Run by
- FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07542379 - No phaseNot yet taking people in KínaAI-Assisted Patient Support in mHSPC
- Where
- Fuzhou, Kunming, Shanghai, Wenzhou
- Életkor
- 18 év to 80 év
- People
- 160
- Run by
- Fudan University
See details and how to joinNCT07804030 - 2. fázisTaking peopleA Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Where
- Hangzhou, Huaian, Shanghai, Tianjin, Yangzhou
- Életkor
- 18 év and over
- People
- 218 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07005154 · EU 2024-517653-27-00 - 1/2. fázisTaking peopleA Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Where
- Beijing, Chengdu, Guangzhou, Nanjing
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00 - Korai 1. fázisTaking peopleClinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
- Where
- Wuxi
- Életkor
- 18 év and over
- People
- 18
- Run by
- Affiliated Hospital of Jiangnan University
See details and how to joinNCT07798778 - 1. fázisTaking peopleStudy of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT05942001 - 2. fázisNot yet taking people in KínaA Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer.
- Where
- Hefei
- Életkor
- 18 év to 85 év
- People
- 40
- Run by
- Anhui Medical University
See details and how to joinNCT07795177 - No phaseTaking peopleIpsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis
- Where
- Nanjing
- Életkor
- 19 év and over
- People
- 454
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07795723 - 2. fázisTaking peopleProstate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 104
- Run by
- Sun Yat-sen University
See details and how to joinNCT06854250 - No phaseTaking peopleAdjuvant Chemotherapy for High Malignant Prostate Cancer
- Where
- Baoding, Beijing, Shenzhen
- Életkor
- 18 év to 80 év
- People
- 315
- Run by
- Peking University First Hospital
See details and how to joinNCT06864533 - No phaseTaking peopleAn Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 800
- Run by
- Bayer
See details and how to joinNCT07538843 - 3. fázisTaking peopleInvestigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
- Where
- Nanjing, Wuxi
- Életkor
- 18 év and over
- People
- 365
- Run by
- Norroy Bioscience Co., LTD
See details and how to joinNCT07615101